Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal D Shore

Showing results (61-70 of 312) with videos related to

Pageof 32
Sort By:
Clinical Genitourinary Cancer|April 24, 2021
Risk of Cognitive Effects in Comorbid Patients With Prostate Cancer Treated With Androgen Receptor InhibitorsAlicia K Morgans, Joseph Renzulli, Kara Olivier, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 18, 2020
Sorting Through the Maze of Treatment Options for Metastatic Castration-Sensitive Prostate CancerBrian Schulte, Alicia K Morgans, Neal D Shore, et al.
The Urologic Clinics of North America|November 5, 2013
Infusion therapy and implantables for the urologistJennifer Rothschild, Ian M Thompson, Raoul S Concepcion, et al.
Urology Practice|November 2, 2023
Reply by AuthorsMohamad Abou Chakra, Neal D Shore, Rachelle Dillon, et al.
Urologic Nursing|December 21, 2013
Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancerNeal D Shore, Paul Sieber, Leanne Schimke, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2015
Extended release, 6-month formulations of leuprolide acetate for the treatment of advanced prostate cancer: achieving testosterone levels below 20 ng/dlE David Crawford, Judd W Moul, Oliver Sartor, et al.
Urology Practice|October 31, 2023
US Clinical Practice Patterns of Intravesical Chemotherapy for Bacillus Calmette-Guérin-Unresponsive and Bacillus Calmette-Guérin-Exposed Nonmuscle-Invasive Bladder CancerMohamad Abou Chakra, Neal D Shore, Rachelle Dillon, et al.
Clinical Therapeutics|April 2, 2019
A New Sustained-release, 3-Month Leuprolide Acetate Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate CancerNeal D Shore, Sílvia Guerrero, Rosa Ma Sanahuja, et al.
Cancer Treatment Reviews|November 30, 2023
Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancerJason A Efstathiou, Alicia K Morgans, Christopher S Bland, et al.
Urology|July 4, 2012
Treatment patterns in patients with prostate cancer and bone metastasis among US community-based urology group practicesStephen J Freedland, Akshara Richhariya, Huei Wang, et al.
Pageof 32

Showing results (61-70 of 312) with videos related to

Sort By:
Pageof 32
Clinical Genitourinary Cancer|April 24, 2021
Risk of Cognitive Effects in Comorbid Patients With Prostate Cancer Treated With Androgen Receptor InhibitorsAlicia K Morgans, Joseph Renzulli, Kara Olivier, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 18, 2020
Sorting Through the Maze of Treatment Options for Metastatic Castration-Sensitive Prostate CancerBrian Schulte, Alicia K Morgans, Neal D Shore, et al.
The Urologic Clinics of North America|November 5, 2013
Infusion therapy and implantables for the urologistJennifer Rothschild, Ian M Thompson, Raoul S Concepcion, et al.
Urology Practice|November 2, 2023
Reply by AuthorsMohamad Abou Chakra, Neal D Shore, Rachelle Dillon, et al.
Urologic Nursing|December 21, 2013
Comparison of tolerability and adverse events following treatment with two GnRH agonists in patients with advanced prostate cancerNeal D Shore, Paul Sieber, Leanne Schimke, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 22, 2015
Extended release, 6-month formulations of leuprolide acetate for the treatment of advanced prostate cancer: achieving testosterone levels below 20 ng/dlE David Crawford, Judd W Moul, Oliver Sartor, et al.
Urology Practice|October 31, 2023
US Clinical Practice Patterns of Intravesical Chemotherapy for Bacillus Calmette-Guérin-Unresponsive and Bacillus Calmette-Guérin-Exposed Nonmuscle-Invasive Bladder CancerMohamad Abou Chakra, Neal D Shore, Rachelle Dillon, et al.
Clinical Therapeutics|April 2, 2019
A New Sustained-release, 3-Month Leuprolide Acetate Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate CancerNeal D Shore, Sílvia Guerrero, Rosa Ma Sanahuja, et al.
Cancer Treatment Reviews|November 30, 2023
Novel hormone therapy and coordination of care in high-risk biochemically recurrent prostate cancerJason A Efstathiou, Alicia K Morgans, Christopher S Bland, et al.
Urology|July 4, 2012
Treatment patterns in patients with prostate cancer and bone metastasis among US community-based urology group practicesStephen J Freedland, Akshara Richhariya, Huei Wang, et al.
Pageof 32